Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AXDXNASDAQ:ISONASDAQ:RPID On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAXDXAccelerate Diagnostics$0.65$0.03▼$2.09$857K0.22513,448 shs53.64 million shsISOIsoPlexis$0.76$0.86$0.60▼$5.10$30.28M1.3268,375 shsN/ARPIDRapid Micro Biosystems$3.17-4.5%$2.98$0.58▼$4.04$145.52M1.32195,453 shs122,333 shs The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAXDXAccelerate Diagnostics0.00%0.00%0.00%-95.82%-96.84%ISOIsoPlexis0.00%0.00%0.00%0.00%0.00%RPIDRapid Micro Biosystems-4.52%-9.43%-3.06%+17.41%+306.41%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/AISOIsoPlexisN/AN/AN/AN/AN/AN/AN/AN/ARPIDRapid Micro Biosystems1.9383 of 5 stars2.04.00.00.02.52.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAXDXAccelerate Diagnostics 4.00Strong BuyN/AN/AISOIsoPlexis 0.00N/AN/AN/ARPIDRapid Micro Biosystems 4.00Strong Buy$8.00152.37% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAXDXAccelerate Diagnostics$11.70M0.00N/AN/A($1.37) per share0.00ISOIsoPlexis$16.76M1.81N/AN/A$1.04 per share0.73RPIDRapid Micro Biosystems$28.05M4.95N/AN/A$1.75 per share1.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAXDXAccelerate Diagnostics-$61.62M-$2.34N/AN/AN/A-471.83%N/A-191.66%N/AISOIsoPlexis-$106M-$2.70N/AN/AN/A-632.41%-127.86%-71.41%N/ARPIDRapid Micro Biosystems-$46.89M-$1.03N/AN/AN/A-151.22%-56.07%-44.11%8/1/2025 (Estimated)Latest AXDX, RPID, and ISO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025Q1 2025RPIDRapid Micro Biosystems-$0.27-$0.26+$0.01-$0.26$6.63 million$7.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAXDXAccelerate DiagnosticsN/AN/AN/AN/AN/AISOIsoPlexisN/AN/AN/AN/AN/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAXDXAccelerate DiagnosticsN/A1.501.34ISOIsoPlexis1.124.062.50RPIDRapid Micro BiosystemsN/A4.613.23Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAXDXAccelerate Diagnostics17.14%ISOIsoPlexis44.91%RPIDRapid Micro Biosystems52.60%Insider OwnershipCompanyInsider OwnershipAXDXAccelerate Diagnostics43.60%ISOIsoPlexis6.40%RPIDRapid Micro Biosystems29.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAXDXAccelerate Diagnostics22025.21 million14.13 millionOptionableISOIsoPlexis45939.76 million37.22 millionNot OptionableRPIDRapid Micro Biosystems20043.83 million30.70 millionNot OptionableAXDX, RPID, and ISO HeadlinesRecent News About These CompaniesRapid Micro Biosystems, Inc. (NASDAQ:RPID) Sees Large Drop in Short InterestJune 19, 2025 | americanbankingnews.comRapid Micro Biosystems (NASDAQ:RPID) vs. Arrayit (OTCMKTS:ARYC) Head-To-Head ComparisonJune 19, 2025 | americanbankingnews.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Sees Large Decrease in Short InterestJune 18, 2025 | marketbeat.comRapid Micro Biosystems Grants Equity Awards to New Employee as Inducement for EmploymentJune 13, 2025 | quiverquant.comRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 13, 2025 | globenewswire.comCitadel Advisors LLC Buys Shares of 72,024 Rapid Micro Biosystems, Inc. (NASDAQ:RPID)June 11, 2025 | marketbeat.comRapid Micro Biosystems (NASDAQ:RPID) Trading 3.6% Higher - Here's What HappenedJune 3, 2025 | marketbeat.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Short Interest UpdateJune 2, 2025 | marketbeat.comRapid Micro Biosystems Appoints Dr. Dafni Bika to Board of DirectorsMay 29, 2025 | nasdaq.comRapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of DirectorsMay 27, 2025 | globenewswire.comEarnings call transcript: Rapid Micro Biosystems Q1 2025 shows revenue growthMay 10, 2025 | investing.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comRapid Micro Biosystems, Inc.: Rapid Micro Biosystems Reports First Quarter 2025 Financial ResultsMay 10, 2025 | finanznachrichten.deWhy Rapid Micro Biosystems, Inc.’s (RPID) Stock Is Up 26.12%May 9, 2025 | aaii.comRapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue EstimatesMay 9, 2025 | zacks.comRapid Micro Biosystems Reports First Quarter 2025 Financial ResultsMay 9, 2025 | globenewswire.comRapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025April 24, 2025 | globenewswire.comRapid Micro Biosystems, Inc.'s (NASDAQ:RPID) largest shareholders are retail investors with 36% ownership, private equity firms own 33%April 21, 2025 | finance.yahoo.comRapid Micro Biosystems, Inc. (RPID): A Bull Case TheoryApril 4, 2025 | insidermonkey.comIs Rapid Micro Biosystems Inc. (RPID) the Popular Penny Stock on Robinhood to Watch?March 27, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAXDX, RPID, and ISO Company DescriptionsAccelerate Diagnostics NASDAQ:AXDX$0.04 +0.04 (+∞) As of 05/14/2025 This is a fair market value price provided by Polygon.io. Learn more.Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.IsoPlexis NASDAQ:ISOIsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.Rapid Micro Biosystems NASDAQ:RPID$3.17 -0.15 (-4.52%) Closing price 06/23/2025 04:00 PM EasternExtended Trading$3.42 +0.25 (+7.89%) As of 06/23/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
